Navigation Links
ARIUS to Present at American Association for Cancer Research Annual,Meeting

- Lead Programs CD44 and Trop-2 poster Presentations Reveal New Findings -

TORONTO, April 4 - ARIUS Research Inc. (TSX: ARI), a biotechnology company discovering and developing the next wave of antibody therapeutics, today announced that new information on the preclinical activity of two of its novel monoclonal antibodies will be presented at the Annual Meeting of the American Association for Cancer Research (AACR), which runs from April 14-18, 2007 in Los Angeles, California. The first poster presentation will outline the activity of ARIUS' lead anti-CD44 antibody, ARH460-16-2, against liver cancer, a significant market in Asia and a growing concern in North America.

CD44 is an important marker for cancer stem cells that often survive treatment and keep growing to spread tumors. Studies of patients with different types of cancer have shown that CD44 can be linked to poorer chances of survival. ARIUS anti-CD44 antibodies have previously been found to control tumor growth and improve survival in breast and prostate cancer models.

The second poster will describe the activity of two antibodies targeting Trop-2 in a variety of solid tumors including breast and colon cancers plus pancreatic cancer, an area without effective treatment options. Trop-2 is a new target for drugs in cancer. Recently, increasing Trop-2 has been shown to
stimulate tumor growth. Studies in colon cancer patients found it is also associated with more aggressive disease and cancer death.

"Presenting our most recent findings for two of our lead programs, CD44 and Trop-2, is an excellent opportunity to showcase the potential of our products as we look for partners," said Dr. David Young, President and CEO. "Moreover, this important preclinical work also highlights the value and capabilities of our FunctionFIRST(TM) platform to generate novel antibodies with promising anti-cancer properties."

Novel antibody ARH460-16-2 rec
'"/>




Page: 1 2 3 4

Related medicine technology :

1. The Past, Present and Future of HLA Typing
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
5. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
6. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
10. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
(Date:9/18/2014)... Sept. 18, 2014  Aratana Therapeutics, Inc. (NASDAQ: ... focused on licensing, developing and commercializing innovative biopharmaceutical ... exercise of the underwriters, option to purchase 675,000 ... the company,s previously announced public offering of 4,500,000 ... are being offered by Aratana Therapeutics.  With the ...
(Date:9/18/2014)... , Sept. 18, 2014 Research and ... Market Monitor : Global Chiral Separation Columns Market" ... chromatography is a technique involving two enantiomers of the ... consisting of a single enantiomer, thus possessing different elution ... such as cellulose. The chiral separation chromatography ...
(Date:9/18/2014)... , Sept. 18, 2014  Decision Resources ... the United States , 54 ... GlaxoSmithKline,s BRAF inhibitor Tafinlar for BRAF -mutation-positive ... who have prescribed GlaxoSmithKline,s MEK inhibitor Mekinist. Among ... percentage (42 percent and 43 percent, respectively) expects ...
Breaking Medicine Technology:Aratana Therapeutics, Inc. Announces Full Exercise of Underwriters' Option to Purchase Additional Shares 2Micro Market Monitor: Global Chiral Separation Columns Market 2At One Year Post-Launch, Approximately One Half of Surveyed U.S. Medical Oncologists Have Prescribed Single-Agent Tafinlar and Mekinist to Their Malignant Melanoma Patients 2
... The award recognizes outstanding journalism demonstrating the ... discoveries and scientific,breakthroughs., WASHINGTON, June 19 ... announces the winners of the 7th Annual,Michael ... in honor of FBR,s,Chairman and 2008 Congressional ...
... Kendle (Nasdaq: KNDL ), a,leading global full-service ... its experts will present at the upcoming Drug,Information ... scheduled,for June 22-26, 2008, at the Boston Convention ... speak on key topics in the clinical,development industry, ...
Cached Medicine Technology:The Foundation for Biomedical Research Announces Winners of the 7th Annual Michael E. DeBakey Journalism Awards 2Kendle Experts to Present at the Drug Information Association 44th Annual Meeting 2Kendle Experts to Present at the Drug Information Association 44th Annual Meeting 3
(Date:9/18/2014)... Kent, WA Chiropractor Danene Saggau and the ... that Dawn Kelly has agreed to become the new Office ... to Ms. Kelly expanding her role within the practice, noting ... key contributor. “ Dawn Kelly brings to the clinic ... that will allow me to focus on the patient ...
(Date:9/18/2014)... Alexandria, VA — The Public Health ... communities have joined the growing ranks of those reaping ... decisions bring the number of governmental public health departments ... non-profit organization that administers the national public health accreditation ... of the public by advancing the quality and performance ...
(Date:9/18/2014)... -- Older people become more physically vulnerable during bereavement, ... stress hormones during bereavement changes with age, British researchers ... are more likely to have weakened immune systems and ... weeks and months after loss, we can suffer from ... of white blood cell and as such are essential ...
(Date:9/18/2014)... September 18, 2014 It’s been just a ... newest, patent pending bunion splint to website visitors, but already ... wrote: "I was absolutely delighted. It is perfect and I ... am wearing them. THANK YOU FOR LISTENING!!!" Another user ... saying, "The hole used to slip to the end of ...
(Date:9/18/2014)... Alan Mozes HealthDay Reporter , ... to emergency room waiting times, patients seeking care at larger ... the clock than those seen at smaller or more rural ... our ability to provide timely emergency care varies dramatically across ... of the new research, Dr. Renee Hsia, an associate professor ...
Breaking Medicine News(10 mins):Health News:Lake Meridian Chiropractic of Kent, WA Announces that Dawn Kelly Has Been Promoted to the Position of Office Manager 2Health News:Ten More Communities Reaping Benefits of National Accreditation 2Health News:Ten More Communities Reaping Benefits of National Accreditation 3Health News:Ten More Communities Reaping Benefits of National Accreditation 4Health News:Grief Can Weigh on Immune System in Older Folks, Study Says 2Health News:Feedback for the New Bunion Bootie Design Feedback is Already Pouring In, and Bunion Sufferers Love It 2Health News:Feedback for the New Bunion Bootie Design Feedback is Already Pouring In, and Bunion Sufferers Love It 3Health News:ER Waiting Times Vary Significantly, Studies Find 2Health News:ER Waiting Times Vary Significantly, Studies Find 3
... Iran: Revolution and Reproduction has been selected as this year,s ... Year of the Islamic Republic of Iran. Edited by Mohammad ... the first to attempt to explain why the fertility rate ... end of the 20th century. The prize is awarded by ...
... million deaths from cancer in Europe in 2011 according to ... Annals of Oncology today (Wednesday 9 February) [1]. ... for the first time in Europe a new mathematical model ... death rates for both men and women when compared to ...
... Scientific American MIND to present an event just in time ... what makes romantic relationships succeed or fail. The ... 2011, 7:00 PM - 8:30 PM at The New York ... City. According to Columbia University psychiatrist and neuroscientist Amir ...
... by Boston University School of Public Health (BUSPH) researchers ... help smokers quit, producing six-month abstinence rates nearly double ... study published online ahead of print in the American ... of respondents reported having quit smoking six months after ...
... TUESDAY, Feb. 8 (HealthDay News) -- Babies who are exposed ... virus have lower levels of antibodies to diseases such as ... Researchers collected serum samples from 104 HIV-infected and uninfected South ... again from 93 of the infants at 16 weeks of ...
... , TUESDAY, Feb. 8 (HealthDay News) -- In pregnant women, ... significantly higher blood pressure, new research suggests. The study ... had a lead level higher than about 1 microgram per ... lower than the safety thresholds set by the U.S Centers ...
Cached Medicine News:Health News:Researchers predict nearly 1.3 million cancer deaths in Europe in 2011 2Health News:Researchers predict nearly 1.3 million cancer deaths in Europe in 2011 3Health News:Electronic cigarettes hold promise as aid to quitting 2Health News:Mom's HIV May Lower Baby's Immunity to Other Diseases 2Health News:Lead Exposure May Raise Blood Pressure in Pregnancy 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: